Literature DB >> 6606401

C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.

J V Bertouch, P J Roberts-Thompson, P H Feng, J Bradley.   

Abstract

The concentration of C-reactive protein (CRP) in sera from 70 patients with systemic lupus erythematosus (SLE) showed no correlation with commonly accepted laboratory indices of disease activity. Most patients had detectable serum CRP, but in some patients CRP was not found despite repeated testing. This absence of a CRP response did not appear to be related to medication. In some patients high levels of CRP were seen in the absence of infection. Measurement of serum CRP in SLE is unlikely to be useful in the laboratory diagnosis of disease activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606401      PMCID: PMC1001323          DOI: 10.1136/ard.42.6.655

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  C-reactive protein in systemic lupus erythematosus.

Authors:  S Honig; P Gorevic; G Weissmann
Journal:  Arthritis Rheum       Date:  1977-06

2.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

3.  Immunochemical conditions affecting the measurement of DNA antibodies using ammonium sulfate precipitation.

Authors:  T Pincus
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Studies on vasculitis. VII. C-reactive protein as a substance perpetuating chronic vasculitis. Occurrence in lesions and concentrations in sera.

Authors:  W E Parish
Journal:  Clin Allergy       Date:  1976-11

6.  Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus.

Authors:  N Zein; C Ganuza; I Kushner
Journal:  Arthritis Rheum       Date:  1979-01

7.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

8.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Authors:  G J Becker; M Waldburger; G R Hughes; M B Pepys
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; D Cawdell; M Ishii; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

10.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  9 in total

1.  Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.

Authors:  S P Ardoin; L E Schanberg; C Sandborg; E Yow; H X Barnhart; K l Mieszkalski; N T Ilowite; E von Scheven; A Eberhard; D M Levy; Y Kimura; E Silverman; S L Bowyer; L Punaro; N G Singer; D D Sherry; D McCurdy; M Klein-Gitelman; C Wallace; R Silver; L Wagner-Weiner; G C Higgins; H I Brunner; L K Jung; L Imundo; J B Soep; A M Reed
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

2.  Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.

Authors:  Mai Kawazoe; Kaichi Kaneko; Kotaro Shikano; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

3.  The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.

Authors:  E Littlejohn; W Marder; E Lewis; S Francis; J Jackish; W J McCune; E C Somers
Journal:  Lupus       Date:  2018-03-16       Impact factor: 2.911

Review 4.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Authors:  Chandra Mohan; Shervin Assassi
Journal:  BMJ       Date:  2015-11-26

5.  Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations.

Authors:  P Betty Shih; Susan Manzi; Penny Shaw; Margaret Kenney; Amy H Kao; Franklin Bontempo; M Michael Barmada; Candace Kammerer; M Ilyas Kamboh
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

6.  Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts.

Authors:  Kaichi Kaneko; Natsuko Kusunoki; Tomoko Hasunuma; Shinichi Kawai
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

7.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

Authors:  F A Robey; K D Jones; A D Steinberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

8.  Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Authors:  Satu Sinikka Pesickova; Romana Rysava; Martin Lenicek; Libor Vitek; Eliska Potlukova; Zdenka Hruskova; Eva Jancova; Eva Honsova; Jakub Zavada; Marten Trendelenburg; Vladimir Tesar
Journal:  Arthritis Res Ther       Date:  2015-12-24       Impact factor: 5.156

9.  Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases.

Authors:  Natsuki Fujio; Shotaro Masuoka; Kotaro Shikano; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.